Updates are available Correction dated 2022-11-05
Click to view Correction: https://doi.org/10.1007/s00384-022-04277-6
-
Authors
Kneißl, Sarah
Stallhofer, Johannes
Schlattmann, Peter
Stallmach, Andreas http://orcid.org/0000-0002-6101-5244
-
Funding
Funding for this research was provided by:
Universitätsklinikum Jena
- License Information
-
More Information
Article History
Accepted: 18 September 2022
First Online: 23 September 2022
Change Date: 5 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00384-022-04277-6
Declarations
:
: JS received travel support from MSD Sharp & Dohme, AbbVie and Pfizer. PG obtained consulting fees from Janssen and Takeda and lecture fees and travel support from AbbVie, Janssen, Pfizer and Takeda. A Stallmach reports research funding from AbbVie and Celltrion and has received lecture fees from AbbVie, Amgen, Astellas, Biogen, Celltrion, Institut Allergosan, Janssen, Falk Foundation, Ferring, MSD, RecordatiPharma, Streamed-Up and Takeda and consulting fees from AbbVie, Astellas, Amgen, Biogen, CLS Behring, Consal, Galapagos, Hexal, Janssen, MSD, Norgine, Pfizer Pharma, Takeda and Tillots Pharma.
